PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aerial part extracts and the isolated compound vitalboside showed potent anti-inflammatory effects against carrageenan-, serotonin-, and PGE(2)-induced edema, as well as chronic arthritis in mice [PMID: 17118593].
Crude extracts of young shoots demonstrated broad antimicrobial activity against pathogenic yeast and yeast-like microorganisms, with MICs ranging from 1.4 to 12.3 microg/ml [PMID: 12781815].
Silver bio-nanoparticles synthesized from Clematis vitalba extract, in combination with sunitinib and imatinib, were evaluated for synergistic antitumor effects in vitro on HepG2 and HUVEC cell lines [PMID: 40149616].
Evidence summary
PubMed sources
- 1.PMID: 37766370 (2023) — Clematis vitalba Is a Natural Host of the Novel Ilarvirus, Prunus Virus I. · Viruses
- 2.PMID: 38407522 (2024) — Viability and dormancy of the Clematis vitalba aerial seed bank. · Plant biology (Stuttgart, Germany)
- 3.PMID: 40149616 (2025) — Synergistic Effects of Green Nanoparticles on Antitumor Drug Efficacy in Hepatocellular Cancer. · Biomedicines
- 4.PMID: 17118593 (2007) — Clematis vitalba L. aerial part exhibits potent anti-inflammatory, antinociceptive and antipyretic effects. · Journal of ethnopharmacology
- 5.PMID: 15554156 (2004) — Isolation and structures of two divinyl ether fatty acids from Clematis vitalba.